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ABSTRACT 
 
The skin is a well-known target of thyroid hormone (TH). TH action is finely controlled by 
the deiodinase family of enzymes, responsible of the tissue-specific activation and 
inactivation of the prohormone thyroxine (T4).  
 
We report that the type 3 deiodinase (D3), the principal terminator of TH action, is required 
for the normal epidermal proliferation. D3-depleted keratinocytes show a proliferative 
defect, associated with a trend toward early differentiation. K14CRE-Dio3Fl/Fl mice, in the 
absence of D3 only in epidermis, present an alterated epidermal phenotype characterized by 
a thinner epidermis, reduced levels of K14 (specific marker for the basal proliferating cells) 
and slowed T4 clearance. These manifestations affect on epidermal regeneration processes in 
which a proper balance between cellular proliferation and differentiation is strictly required. 
We found a massive induction of D3 during early phases of wound healing, when the 
cellular environment requires an increased proliferation necessary to repair the damage. 
Moreover, K14CRE-Dio3Fl/Fl mice show a defective wound repair compared to WT mice, 
with a delayed wound closure, caused by a decrease of proliferation. 
 
In conclusion, we show that the D3 enzyme is employed to attenuate TH-signaling in skin, 
providing a striking example of how a circulating hormone can be tissue-specifically 
attenuated to influence local requirement. 
 
 
 
 
Key words: type 3 deiodinase, thyroid hormone, skin, wound healing 
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INTRODUCTION 
 
Thyroid hormones (THs) influence several cellular activities including proliferation, 
differentiation and apoptosis in virtually all mammal cells. The canonical action of TH is its 
binding to ligand-dependent transcription factors, namely, TH receptors (TRs). The latter 
enhance or inhibit the expression of target genes by binding to specific DNA sequences, 
known as TH response elements (TREs). An initial step in the activation of TH is its 
transport across the cell membrane. Indeed, TH uptake is specifically regulated by different 
types of TH-transporting proteins [1]. Among them there are organic anion transporters 2 
and 3 (Oatp2 and Oatp3), L-type amino acid transporters (Lat1 and Lat2), and 
monocarboxylate transporters 8 and 10 (MCT8 and MCT10) [2-3]. These transporters are 
differentially expressed in several tissues in a developmental and cell-type specific fashion 
[4]. Moreover, although some transporters are able to carry different solutes (e.g. thyroxine 
(T4), triiodothyronine (T3), 3,3’,5’-Triiodo- L-thyronine (rT3), 3,3’-diiodo-L-thyronine 
(T2)) [5] , other transporters have a high substrate specificity [6]. At nuclear level, TH action 
is triggered by its interaction with specific nuclear receptors, TRa and TRb, which directly 
bind the TRE sites on DNA and activate or repress gene expression. TRα and TRβ are 
encoded by the THRA and THRB genes, respectively [7]. Several cells and tissues express 
various isoforms of each TH receptor protein, for example receptors TRα1, TRβ1 and TRβ2. 
Among these, TRα1 and TRβ1 mRNAs and proteins are widely expressed in several tissues, 
however, their expression is locally modulated. For example in rats, TRα1 mRNA is mainly 
expressed in skeletal muscle and brown fat, whereas TRβ1 mRNA is mainly expressed in 
brain, liver and kidney. Ligand availability and the concentration of the TR-TH complex in 
the nucleus ultimately define the level of TR transcription activity. Upon binding to T3, TR 
undergoes a conformational switch that results in the release of the co-repressor and 
recruitment of multiple co-activator proteins to the TR-TRE complex in a sequential manner. 
Those cofactor changes lead, in TH-positively regulated target genes, to local chromatin 
remodelling and increase transcription [7].  
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A crucial step in the control of TH intracellular availability is given by the action of three 
thioredoxin fold-containing selenoenzymes, called “deiodinases”. These enzymes metabolize 
THs in a stage- and tissue-specific manner  by a mono-deiodination reaction that involves 
two distinct pathways. The type I and II deiodinases (D1 and D2) catalyze the outer ring 
deiodination thus converting the inactive precursor T4 to the active form T3 — a process that 
increases circulating T3 levels and the availability of the active hormone for the nuclear 
receptors [8]. In contrast, type III deiodinase (D3) inactivates TH by converting T4 and T3 to 
the inactive metabolites reverse T3 (rT3) and T2, respectively. All three deiodinases are 
integral membrane proteins that share a ~15 amino acid long conserved region within the 
active center coding for a selenocysteine. The subcellular localization varies among the three 
enzymes, and this affects their systemic versus cellular contributions to TH homeostasis [9]. 
In particular, D1 is an integral plasma membrane protein and D2 is an endoplasmic reticulum 
resident protein. D3 is mainly localized within the plasma membrane, and is recycled 
through the endosomes and is often found in other subcellular localizations [10]. In terms of 
enzymatic efficiency, D2 is considered the principal activator of TH action at intracellular 
level, whereas D3 is the principal terminator of TH action. Notably, the combined actions of 
D2 and D3 are viewed as a cell autonomous pre-receptoral mechanism that controls TH 
signalling in a time- and tissue-specific manner although it does not affect serum hormone 
concentrations. In contrast, D1 is an enzyme with a low kinetic efficiency. It plays a 
significant role in circulating T3 levels. In fact, D1-generated T3 equilibrates with plasma 
more rapidly than D2-generated T3 which has a much longer intracellular resident time [11]. 
The ability of D1 to dehalogenate iodine metabolites suggests that it could also act as a 
scavenger enzyme that recycles iodine to replenish the thyroid’s iodine reservoir (Fig.1). 
 
 
 
 
 
 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D3 - the main physiologic inactivator of TH - is thought to control TH homeostasis by 
protecting tissues from an excess of TH. It is abundantly present in fetal tissues and high D3 
levels are expressed in the human placenta, where it blocks the excessive maternal-to-fetal 
transfer of T4. In contrast, during late neonatal and adult life, D3 expression is more limited, 
and under regulation by tissue specific agents. Thus far, D3 activity has been identified in 
only a limited number of postnatal tissues, i.e., skin, brain, and pregnant uterus [12-13]. Of 
note, several studies have revealed the re-expression of D3 in different pathophysiological 
conditions, among which cardiac hypertrophy, chronic inflammation, critical illness [14-15], 
hypoxia or ischemia [16] and cancer. We have recently demonstrated that D3 is up-regulated 
in basal cell carcinoma [17] and in colon carcinoma [18-19] as well as in hemangiomas [19-
20], astrocytomas [21], pituitary gland adenoma [22] and glioblastoma [21]. Because of its  
Fig.1: Structures of the iodothyronines differentially activated or inactivated by the deiodinases. 
3,5,3’,5’-tetraiodo-L-thyronine (thyroxine, T4) is converted into 3,5,3’ triiodo-L-thyronine (T3) 
by two iodothyronine deiodinases, D1 and D2, by phenolic outer ring deiodination. T4 and T3 
are respectively inactivated in 3,3’,5’-triiodo-L-thyronine (reverse T3) and 3,3’-diiodo-L-
thyronine (T2) by phenolic inner ring deiodination catalyzed by type 3 deiodinase, D3. (Sibilio 
A., Minerva Endocrinol 2012) 
 
 9 
 
presence in fetal as well as in malignant tissues, D3 is referred to as an “oncofetal enzyme”. 
The human type 3 iodothyronine deiodinase (DIO3) gene was cloned in 1995 [23] and 
subsequently localized to chromosome 14q32 [24]. In contrast to human DIO1 and DIO2 
genes, which contain four and two exons, respectively, D3 genomic structure contains a 
single exon encompassing 1,853 nucleotides. Two other major features of the mouse Dio3 
gene are that: i) its sequence in both the coding and 3′-UTR regions has been highly 
conserved among diverse species; and that ii) its promoter region, which is located within 78 
bp of the translational start site, is highly GC enriched (80%), containing a TATA box that is 
critical for its function as well as CAAT and GC boxes. The human DIO3 gene is positioned 
870 kb downstream of two imprinted genes, DLK1 and GLT2. In the mouse, D3 is the last 
imprinted gene at the telomeric end of the imprinted domain Dlk1/Gtl2, and is preferentially 
expressed from the paternal allele both in human and mouse [25-26]. 
The genetic mouse model of D3-deficiency has been instructive in understanding the role of 
D3 with regard to fertility and developmental processes. Both male and female D3KO mice 
showed impaired fertility, significant perinatal mortality and growth impairment [27]. In 
addition, the developmental programming of the thyroid axis is perturbed in the D3KO 
mouse, presumably due to the overexposure of the animal to excessive levels of TH in utero 
and during the first weeks of perinatal life. Early in life, D3KO mice have a delayed T3 
clearance with markedly elevated serum T3 level. From postnatal day 15 to adulthood, 
D3KO mice demonstrate central hypothyroidism, with low serum levels T4 and T3, and 
modest or no increase in thyroid-stimulating hormone (TSH) concentration. The thyrotoxic 
status in the D3KO newborn evolves to hypothyroidism after 2 weeks of life, and this 
persists in adulthood. This is accompanied by tissue hypothyroidism, as demonstrated by a 
marked decrease in liver expression of T3-inducible genes. The nature of this 
hypothyroidism is clearly central, as serum TSH is suppressed, unchanged, or only slightly 
elevated in D3KO at different stages despite the low serum concentrations of both T4 and 
T3. In the adult, a 50% increase in TSH is observed in the presence of low T4 and T3 levels 
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[27]. Thus, the D3KO mouse manifests marked abnormalities in thyroid status and 
physiology, which underscores the critical role of the D3 enzyme in the development and in 
the function of the hypothalamic-pituitary-thyroid (HPT) axis (Fig.2). Interestingly, the 
abnormalities of the HPT resemble those observed in children born to mothers affected by 
hyperthyroidism during pregnancy [28-29]. However, refinement and optimization of the 
animal models such as the generation of a conditional Dio3- KO mouse will provide useful 
tools to advance our molecular understanding of D3's role in development and its specific 
role in local tissue physiology.  
 
 
 
 
 
 
 
 
 
 
Thyroid hormone action and skin 
 
The skin is a well-recognized target of thyroid hormone, which is an important regulator of 
epidermal homeostasis. The skin, which protects organisms from the external environment, 
is comprised of a stratified epithelium, the epidermis, separated by a basement membrane 
from the underlying connective tissue, the dermis. After birth, its role is to guard against 
infection, to prevent dehydration, and to undergo re-epithelialisation after wound injuries. To 
Fig. 2: Mouse D3 knockout model. D3KO mice exhibit growth impairment and alterated 
maturation and function of thyroid axis [27]. 
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accomplish these feats, the epidermis constantly replenishes itself by a process of 
homeostasis. During this process, dividing cells in the innermost (basal) layer continually 
execute a programme of terminal differentiation, move outwards and are sloughed from the 
skin surface. When expose to physical trauma and chemical assaults the epidermis must also 
protect itself, which it does by producing copious amounts of cytoplasmic heteropolymers 
known as intermediate filaments that are composed of keratin proteins. As cells exit from the 
basal layer and begin their journey towards the skin surface, they switch from the expression 
of keratins K14 and K5 to K1 and K10 [30-31]. This switch was discovered more than 30 
years ago, and remains the most reliable indication that an epidermal cell has undergone a 
commitment to terminally differentiate. The first suprabasal cells are known as spinous cells, 
reflecting their cytoskeleton of K1/K10 filament bundles connected to robust cell–cell 
junctions known as desmosomes. These connections provide a cohesive, integrated 
mechanical framework across and within stacks of epithelial sheets. K6, K16 and K17 are 
also expressed suprabasally, but only in hyperproliferative situations such as wound healing 
[32-33].  
                          
 
 
Normal TH levels are required for efficient epidermal homeostasis, function and 
regeneration. Moreover, TH action is crucial in the balance between proliferation and 
Fig. 3: Scheme of epidermal layers of the skin with the expression of the specific markers.  
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differentiation in normal and pathological conditions, including epidermal regeneration and 
cancer [34]. In skin, TH exerts profound effects on fetal epidermal differentiation, barrier 
formation, hair growth, sebum production, wound healing, epidermal oxygen consumption, 
keratinocyte proliferation, and keratin gene expression [35-38]. Besides, several TH 
responsive genes have been identified in skin. For example, TH  stimulates the K5, K14, and 
K17 gene promoters [36] and the hairless promoter is also differentially regulated by TH in 
keratinocytes [39]. Moreover, TH affects many cell cycle genes: cyclin D1, Mdm2, Myc, 
p21, p53 [40-41].    
Direct thyroid hormone action on skin is mediated through TRs [42-44]. All three widely 
recognized thyroid hormone binding isoforms of TR have been identified in skin tissues. 
TRα have been detected in epidermal keratinocytes, skin fibroblasts, hair arrector pili muscle 
cells, other smooth muscle cells, sebaceous gland cells, vascular endothelial cells, Schwann 
cells, and a number of cell types that make up the hair follicle [42]. TRβ1 was the 
predominant form of TR expressed in the human hair follicle [43]. In addition, TRβ1 acts as 
a potent suppressor of tumor invasiveness and metastasis in chemical skin carcinogenesis. 
TR deficiency seems to inhibit benign tumor formation at early stages of skin carcinogenesis 
while increasing malignant progression at later stages [44]. Moreover, TRα and TRβ mediate 
effects of thyroid hormone on epidermal proliferation. The epidermis of knockout mice 
lacking the TH binding isoforms TRa1 and TRb shows reduced keratinocyte proliferation. 
Defective proliferation is associated with reduction of cyclin D1 expression and up-
regulation of the cyclin-dependent kinase inhibitors p19 and p27 [45]. TRKO mice show 
decreased hyperplasia in response to topical application of 12-O-tetradecanolyphorbal-13-
acetate (TPA), a well-known model for induction of skin hyper-proliferation and 
inflammation [45]. Anyway, available data in the literature show that the function of THs 
and of their receptors on cell proliferation is not homogenous. In fact, it strongly depends on 
the cell type, its developmental state (progenitor or differentiated), its patho-physiological 
state (normal or tumor cell), and the so-called ‘cellular context’. For example, T3 activates 
proliferation of hepatocytes after partial hepatectomy and is considered a primary liver 
 13 
 
mitogen [46-47]. It induces proliferation of cultured bovine thyroid cells, of bone marrow 
pro-B cells [48], of pancreatic acinar cells [49-50], and of renal proximal tubular epithelial. 
Finally, it increases DNA synthesis in osteoblasts [51]. On the other hand, T3 treatment 
blocks proliferation and induces differentiation of oligodendrocyte progenitor cells of 
neuroblastoma N2a-β cells [52], and of erythroid progenitors [53]; it also prevents cycling of 
postnatal Sertoli cells [54] [55], as well as of mammary epithelial cells. Also in the skin the 
effects of TH on keratinocyte proliferation and epidermal differentiation are controversial, 
with divergent results [35]. Safer's group has found that systemic and topical TH 
administration cause diverging effects on keratinocyte proliferation. While topical T3 
stimulates epidermal proliferation, hair growth, dermal thickening and accelerates wound 
healing in mice [56-58], systemic thyrotoxicosis leads to thinning of skin, hair and collagen 
loss [57]. The authors postulate that the different effects exerted by topical versus systemic 
TH treatment on epidermal cell can be explained by the T3-induced production of inhibitory 
factors from fibroblasts with systemic T3-treatment. In addition, Zhang B et al. have recently 
showed thyroid hormone analogue stimulates keratinocyte proliferation but inhibits cell 
differentiation in epidermis [59]. In contrast, Tiede et al. have demonstrated that THs reduce 
proliferation, Cyclin D1 expression and induce apoptosis of isolated K15-GFP+ cells (K15, 
marker of human epithelial hair follicle stem cells). THs reduce the viability of human hair 
follicle epithelial progenitor cells in vitro, caused by combination of cell death and growth 
arrest [60].  
In keeping with the ability to modulate growth and differentiation, it is not surprising that 
TH might play a critical role in skin. Indeed thyroid dysfunction is correlated with alterations 
in skin architecture and homeostasis [61] and changes in circulating TH levels, particularly 
hypothyroidism, are often associated with an edema-like-associated skin condition caused by 
increased glycosaminoglycan deposition. The skin exhibits typical abnormalities in 
hyperthyroidism and hypothyroidism [37, 62]. In hyperthyroidism, skin changes include 
erythema, palmoplantar hyperhidrosis, acropathy, and infiltrative dermopathy; also, Graves’ 
disease may be associated with generalized pruritus, chronic urticaria, alopecia areata, 
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vitiligo, and diffuse skin pigmentation. In hypothyroid humans the skin is cool and dry with 
a pasty appearance, the epidermis is thin and hyperkeratotic, alopecia may develop, and there 
is diffuse myxedema [61], showing that thyroidal status influence skin morphology and 
function.  
Finally, conflicting evidence are present in the literature about TH action in epidermal 
regeneration processes, as wound healing. Healing of wounds is one of the most complex 
biological events afterbirth as a result of the interplay of different tissue structures and a 
large number of resident and infiltrating cell types. Indeed, wound healing is an interactive 
process that involves soluble mediators, extracellular matrix components, resident cells 
(keratinocytes, fibroblasts, endothelial cells, nerve cells), and infiltrating leukocyte subtypes, 
which participate differentially in the classically defined three phases of wound healing: 
inflammation, tissue formation, and tissue remodelling [63-64]. Safer’s data affirm that the 
topical application of supraphysiologic doses of T3 accelerates wound healing in mice, but at 
the same time intraperitoneal injection of T3 do not have wound healing acceleration beyond 
that of control mice [58]. In addition, the L-thyroxine replacement therapy in 
hypothyroidism cases was beneficial with regard to wound healing [65]. In contrast, Pirk et 
al. noted no change in wound healing with euthyroid hamsters receiving ip T4 [66].  
 
Type 3 deiodinase  
 
As stated previously, TH signalling is also modulated locally by the deiodinases. The 
expression of D2 and D3 can be exquisitely cell-specific and change rapidly in response to a 
number of developmental, metabolic, and disease cues through different signaling pathways 
[14]. Because the expression of these enzymes can be turned on or off in discrete groups of 
cells, most of the time their actions do not affect circulating thyroid hormone levels, which 
are tightly controlled via the TRH/TSH axis. Thus, the actions of D2 and D3 are viewed as a 
cell-specific pre-receptor mechanism to control thyroid hormone signaling that cannot be 
predicted based on the levels of circulating TH [14]. 
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The presence of D3 activity in skin is dating to 1985, when Huang TS et al. demonstrated 
that “skin is an active site for the inner ring monodeiodination of thyroxine to 3,3',5'-
triiodothyronine” [67]. Subsequently, various studies showed that D3 protein is present in 
both mouse and human skin [17, 68-70]. D3 is first expressed in the mouse epidermis at 
E13.5; it is highly expressed in the epidermal layers and in hair follicle keratinocytes at 
E17.5. D3 expression is very high in anagen (growing) phase of the hair follicle cycle, as 
well as in the surrounding outer root sheath [17]. The characteristic re-expression of D3 in 
many tissues in disease states, as well as in tumoral tissue [15] occurs also in skin. Indeed, a 
striking model of D3-mediated TH regulation in cancer is provided by the presence of D3 in 
basal cell carcinoma (BCC) [17], which is the most frequent human cancer. This carcinoma 
is formed upon constitutive activation of the Shh-Gli pathway. The morphogen Shh, through 
the transcriptional factor Gli2, directly induces D3 mRNA and protein in proliferating 
keratinocytes and in mouse and human BCCs, whereas it promotes D2 degradation via the 
E3 ubiquitin ligase adaptor (WSB-1) [71]. Indeed, Gli2-induced D3 reduces intracellular TH 
activity, thus resulting in increased cyclin D1 and keratinocyte proliferation. Conversely, D3 
knockdown in BCC cells causes a drastic reduction in cell proliferation and consequently a 
five-fold reduction in the growth of BCC xenografts in nude mice in vivo [17]. However, the 
exact role of D3 in initiation-growth-progression of tumorigenesis is not clear. The restricted 
range of tumors associated with D3 overexpression suggests that initiation of tumorigenesis 
does not necessarily require D3, and perhaps modulation of D3 expression is only one of the 
multiple mechanisms adopted by tumoral cells to escape the differentiative action of T3.  
Interestingly, the reactivation of D3 has been also documented in many patho-physiological 
conditions in which cell proliferation is enhanced, namely in liver and neural regeneration, 
cardiac hypertrophy [72-74]. Recent studies on the involvement of D3 in tissue injury have 
shed light on its role in the control of cell proliferation. An explicative model is provided by 
liver regeneration induced by partial hepatectomy in animal models [72]. In these studies, D3 
expression was strongly induced in the liver of mice and rats. Enhanced D3 activity in 
regenerating liver correlated with increased BrdU incorporation and reduction of local and 
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systemic T3 and T4 levels [72]. Moreover, our studies offer a new tissue regeneration model 
in which deiodinases are finely regulated.  It is represented by skeletal muscle regeneration. 
In particular, we demonstrated that TH produced by D2 is essential for normal mouse 
myogenesis and muscle regeneration. Indeed, D2-mediated increases in T3 were essential for 
the enhanced transcription of myogenic differentiation 1 (MyoD) and for execution of the 
myogenic program. Conversely, the expression of T3-dependent genes was reduced and after 
injury regeneration markedly delayed in muscles of mice null for the gene encoding D2 
(Dio2), despite normal circulating T3 concentrations [75].  
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AIM OF THE STUDY 
 
The goal of this project was to evaluate the role of Type 3 deiodinase (D3) in the normal skin 
and during epidermal regeneration as in the wound healing process. Although mounting 
evidence suggests that TH plays an important role in epidermal proliferation, the physiologic 
role of thyroid hormone in skin is not well understood. In order to analyze D3 function in 
epidermis regeneration, we generated a conditional mouse model in which D3 is depleted 
only in the cells of the basal layer in the epidermis and compared regenerative ability of 
epidermis in the presence or absence of D3. The data obtained from this study might prompt 
to understand the role of TH in wound repair and to exploit TH regulation as a new efficient 
strategy to treat cutaneous diseases, in which a proper balance between proliferation and 
differentiation is required.   
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RESULTS 
 
Type 3 deiodinase is highly expressed in adult skin 
The presence of D3 activity in adult skin has been demonstrated for the first time by Huang 
TS et al in 1985. Skin is an active site for the inner ring monodeiodination of thyroxine to 
3,3',5'-triiodothyronine [67]. Moreover, it has been recently demonstrated that D3 is the 
primary deiodinase active in murine epidermis [70], but the specific localization of D3 
protein in adult skin structures is still unknown. The Fig.4 shows the profile of D3 protein 
expression in telogen phase of hair follicle cycle of the mouse skin. By 
immunohystochemical analysis, we observed that D3 protein is highly expressed in the bulge 
region, in sebaceous gland of hair follicle and is absent in the dermal papilla. In addition, D3 
protein is also detectable in infundibulum cells and is extended with the interfollicular 
epidermis (Fig.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4: D3 is specifically expressed in mouse skin. Paraffin sections of mouse skin in telogen 
phase of the hair follicle cycle were probed with D3-718 antibody. D3 was highly expressed 
in the bulge, sebaceous gland of hair follicle, but it is absent from the dermal papilla. D3 is 
evident in infundibulum cells and it is extended in interfollicular epidermis, as well as 
detectable in panniculus carnosus.   
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D3 is induced in the early phase of wound healing 
Since D3 is critical for proper cell proliferation in different conditions [17-18, 75], we asked 
whether D3 plays a role in wound healing process. Notably,  regeneration of the epidermis 
after wounding is a complex and dynamic process consisting of various sequential phases 
[63-64]. It involves activation, migration and proliferation of  keratinocytes from both the 
surrounding epidermis and the adnexal structures such as the hair follicle and sweat gland 
[76-77]. Repair of tissue is a self-limiting process and in response to wounding is activated 
an interplay of different cell types, such as epithelial, mesenchymal and immune cells, 
recalled to invade the underlying dermis. During wound healing, bulge stem cells mobilize, 
leave their stem cell niche and contribute to repopulation in the basal layer of the epidermis 
[77]. In order to investigate the role of D3 in wound repair process, we performed a wound 
healing experiment in vivo. First, we examined the expression patterns of D3 following 
wound created in the dorsal skin in WT mice. Three days after full-thickness injury, 
expression levels of Dio3 mRNA and D3 protein increased significantly in the epidermal 
keratinocytes and reached a peak at day 6 and then declined at day 10, when the healing 
process is almost completely terminated (Fig.5). These data indicate that D3 is induced in 
vivo during regeneration of adult skin, causing tissue-specific reduction of TH signaling in 
epidermal cells.  
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Generation of a conditional skin-specific knock out mouse 
The identification of D3 in epidermal cells prompted us to investigate its specific function in 
the epidermal context. What is the role of D3 in the skin? To answer to this question, we 
generated a basal layer cell-specific (K14-CRE) conditional Dio3 knock-out mouse 
(K14CRE-Dio3Fl/Fl) (see Materials and Methods), in which the expression of recombinase 
Fig. 5: D3 expression is induced during early phase of wound repair. (a) D3 mRNA expression 
during wound healing was measured by real time PCR analysis. The wounds were either 
embedded for sectioning or excised including 2mm of the epidermal margins for RNA isolation, 
at 3, 6, 10 days after injury. Cyclophilin A was used as internal control. Normalized copies of 
the target gene in adult healthy skin were set as 1 and it corresponds at day 0. Data are shown 
as average of 3 separate experiments analyzing 4 mice for each group. (b)Western Blot analysis 
was performed using our anti-D3 ab(717) and anti-Total ERK ab was used to normalize. (c) 
Immunohystochemical staining of D3 was executed on 6 um sections of skin with anti-D3 
Ab(718). 
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Cre induces loss of D3 activity in epidermal cells. Indeed, we used a Cre expressed under the 
control of the keratin 14 gene (K14) promoter and responsible for ubiquitous recombination 
in hair follicles and basal cells of epidermis at E15.5 [78]. We crossed K14CRE mouse with 
our Dio3 floxed mouse (Dio3Fl/Fl, that in this thesis we will name WT mice), in which two 
Lox sites flank the SECIS sequence, necessary for proper D3 protein translation. The SECIS 
element is responsible for the incorporation of a selenocysteine residue in the catalytic 
domain and for the recognition of UGA as a codon for Sec rather than as a stop signal [79]. 
When the Cre acts, the loss of the SECIS, induces a premature termination of protein 
translation (Fig. 6a). The epidermis is a dynamic tissue in which keratinocytes proliferate in 
the basal layer and undergo a tightly controlled differentiation program upon migration into 
the suprabasal layers. Since the keratinocytes in the basal layer do express the CRE, and will 
constitute the upper layers, the K14CRE-Dio3Fl/Fl mice will result in the depletion of D3 
from the entire epidermis. The Fig.6b shows the reduction in D3 protein following CRE 
expression. In this context we speculated that K14CRE-Dio3Fl/Fl skin becomes 
“hyperthyroid” at nuclear level, in contrast with the skin normal TH serum levels that we 
measured in K14CRE-Dio3Fl/Fl mice.  
 
 
 
 
 
 
 
 
 
 
Fig.6: Generation of a conditional skin-specific knock out mouse. (a) Diagram of the Dio3 locus 
modified with the Lox sites. These sites were introduced surrounding the SECIS element into the 3’-
UTR region of the Dio3 locus. The image shows the WT and rearranged D3 allele after K14CRE 
action. (b)The Western Blot analysis shows the effective D3 reduction in K14CRE-Dio3Fl/Fl skin, 
caused by an anticipated termination of D3 protein translation. 
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Characterization of the epidermis in the K14CRE-Dio3Fl/Flmice  
The analysis of D3-depleted skin showed a significant reduction of epidermal thickness in 
K14CRE-Dio3Fl/Fl mice versus WT as demonstrated by Hematoxylin and Eosin staining. 
K14CRE-Dio3Fl/Fl mice present a thinner epidermis more than 40% thinner than WT 
epidermis (Fig. 7a). Moreover, to understand if this morphologic alteration derives from a 
defect in keratinocytes proliferation, we measured expression levels of K14, a specific 
marker of basal proliferating cells [36, 80]. We found that K14 RNA and protein levels were 
reduced in K14CRE-Dio3Fl/Fl skin with respect to WT skin (Fig.7b). This data is in 
agreement with already known T3-mediated repression on K14 promoter [36, 80], and 
support the concept that T3 signaling is over-active in the K14CRE-Dio3Fl/Fl skin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.7: Alterated epidermal phenotype of K14CRE-Dio3Fl/Fl mice (a) Hematoxylin and eosin staining 
of K14CRE-Dio3Fl/Fl and WT skin and measure of epidermal thickness (um) calculated with 
LCMicro Software. Scale bar: 50 um. Each bar represents the average ± SEM of determinations in 
6 animals for group (P<0,01). (b) mRNA and protein K14 expression in adult K14CRE-Dio3Fl/Fl and 
WT skin. For WB analysis 4ug of proteins were used and the levels were normalized with ERK-Tot. 
mRNA levels were normalized to Cyclophilin A. Each bar represents the average ± SD of 
determinations in 4 animals for group.     
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Type 3 deiodinase is critical in the control of the proliferation in primary mouse 
keratinocytes  
T3  often acts as a differentiating agent, controlling the balance between proliferation and 
differentiation. This occurs in many cellular systems [18, 60] and we have previously shown 
that proliferation is reduced by T3 treatment in basal cell carcinomas, one of the most 
common tumors in humans [17]. Using the same rationale, we hypothesized that D3-
depletion would impact on the proliferation of primary keratinocyte. To demonstrate this, we 
grew colture primary keratinocytes from Dio3Fl/Fl mice. Adeno-CRE (Ad-CRE) infection of 
these keratinocytes resulted in effective D3 depletion, with a genomic rearrangement of 
about 90% of the total genomic DNA (Fig.8a), in agreement with the genetic strategy used. 
In keratinocytes infected with Ad-CRE versus Ad-GFP, we observed that the cellular 
proliferation was reduced. This was demonstrated by measurement of BrdU incorporation 
and by the decreased Cyclin D1 mRNA levels (Fig.8b).  
 
 
 
 
– 
 
 
 
 
 
  
 
 Fig.8: D3 is critical in the control of the proliferation in primary mouse keratinocytes. (a) % D3 
genomic rearrangement was measured in primary mouse keratinocyte (Dio3Fl/Fl)and infected with 
AdCRE and AdGFP. (b) Immunofluorescent staining with anti-BrdU antibody was performed at 
48h from the infection. Percentage of BrdU-labeled nuclei wa evaluated as BrdU+ nuclei/Tot 
nuclei. n = 50 fields, P < 0.01. Cyclin D1 mRNA levels were measured from AdCRE and AdGFP 
keratinocytes. Data are shown as average ± SD. 
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Altered morphology was observed in Ad-CRE infected keratinocytes, which showed smaller 
and rounded form, which suggested an early differentiation (Fig.9a). Keratinocytes are 
cultured in medium containing low concentration of calcium ions. In this condition 
desmosome assembly is inhibited and the cells fail to stratify, with differentiated cells 
detaching into the culture medium. The morphologic aspect of Ad-cre infected keratinocytes 
seemed typical of cells which are closed to detaching from the plate. Therefore, we measured 
specific differentiation markers: K1, specifically expressed in the spinous and granular 
layers; Loricrin, characteristic of granulosum stratum; Pvrl4, a cell adhesion molecule 
mainly implicated in the formation of cadherin-based adherens junctions [81]; desmoglein 1 
(Dsg1), an epidermal adhesion molecule [82]. All those markers were induced different fold 
in D3-depleted keratinocytes (Fig.9b), suggesting that local excessive TH drives the cell 
towards a functional differentiation.  
 
 
 
 
 
 
 
 
 
This was similar to what observed in WT keratinocytes growing with exogenous different 
TH concentrations (data not shown), while this did not occur in D2Fl/Fl keratinocytes (derived 
by the Dio2Fl/Fl mice) infected with Ad-CRE. In these latter cells, the absence of D2 in 
primary keratinocytes did not affect the proliferative or differentiative capacity.  
 
Fig.9: (a) Morphology of AdCRE and AdGFP primary mouse keratinocytes cultured in low 
calcium conditions (Scale bar: 100um). (b) K1, Loricrin, Dsg1 and Pvlr4 mRNA expression levels 
were measured from AdCRE and AdGFP keratinocytes. Data are shown as average ± SD. 
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These in vitro data indicate that D3, by inactivating TH, is a critical modulator of cellular 
proliferation and that hyperthyroid conditions act as a differentiating agent in primary 
keratinocytes. In addition, the results obtained in D2Fl/Fl keratinocytes underline the 
specificity of the cellular effects obtained with D3-depletion and support the concept that D3 
is the primary active deiodinase in murine epidermis [70]. 
 
Defective epidermal regeneration in K14CRE-Dio3
Fl/Fl 
mice following epidermal wound 
Since D3 is highly induced during the wound process, we speculated that D3 might play a 
critical role in the regulation of epidermal regeneration. To test this hypothesis, we compared 
the regeneration potential of K14CRE-Dio3Fl/Fl mice versus WT animals during the wound 
healing process. We first evaluated changes in wound area as a measure of wound closure in 
WT and K14CRE-Dio3Fl/Fl mice. In WT mice, wound areas were reduced with linear kinetics 
throughout the 10-day period of observation, at the end of which ~90% closure was 
observed. In contrast, wound closure was significantly delayed in K14CRE-Dio3Fl/Fl mice, 
which showed a 60% wound closure at 10 days vs 6 days in WT mice, respectively 
(Fig.11a). Notably, the maximal difference was observed at day 3 and 6 after wound, when 
 
Fig.10: Dio2Fl/Fl primary mouse keratinocytes. Morphology and BrdU incorporation analysis. 
Scale bar:100um  
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proliferation in the basal layer cell is highly active and D3 expression is induced. 
Histological examination revealed an effective delay in cutaneous regeneration, as showed 
by the absence of epidermic patch in K14CRE-Dio3Fl/Fl skin at 6 day after wound, in contrast 
to the formation of the normal epidermal layer under the scar in WT skin (Fig.11b).  
 
 
 
 
 
 
 
 
  
 
We speculated that this phenotype could be due to a proliferative defect. Therefore, we 
analyzed cell proliferation at 3 and 6 days after damage, by measurement of BrdU 
incorporation in actively regenerating K14CRE-Dio3Fl/Fl versus WT skin. We observed a 
decrease in keratinocyte proliferation, as demonstrated by reduced number of BrdU+ and 
Ki67+ (data not shown) nuclei in the zone surrounding the wound in D3-depleted skin. To 
obtain a quantitative assessment of proliferation in the two groups, we measured the 
percentage of the BrdU+ nuclei versus the total nuclei. At day 3 and at day 6 after injury the 
BrdU+ nuclei present in K14CRE-Dio3Fl/Fl skin were less than ~50% of what present in 
normal skin (p<0.01) (Fig.12).  
 
 
Fig.11: Defective epidermal regeneration in K14CRE-Dio3Fl/Fl mice following epidermal 
wound. (a) Kinetic analysis of skin excisional wound healing. Wound sites were photographed at 
the time indicated. Representative results from three independent experiments with four animals 
in each group are shown. Quantization of data of changes in percentage of wound area at each 
time point in comparison to the original wound area. Values represent mean ± SEM. *, p< 0.01, 
WT vs K14CRE-Dio3Fl/Fl mice. (b) H&E staining of the healing process at the time indicated. 
Scale bar:500um. 
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To confirm with a different approach the presence of a proliferation deficit, we measured 
proliferation markers such as Cyclin D1 and K14. Cyclin D1 and K14 mRNA and protein 
levels were strongly reduced in D3-depleted skin (Fig.13), which indicates that normal 
proliferation after wound is impaired by the absence of D3. 
 
 
 
 
 
 
 
 
 
Fig.12: Reduced proliferation capability in wound area in K14CRE-Dio3Fl/Fl mice. 
Immunofluorescent staining for BrdU positive nuclei and K14 protein (used as control of 
analyzed epidermal area) in sections of skin at 6 days from injury in WT vs K14CRE-
Dio3Fl/Flmice. The quantization of the proliferation rate is showed in graph as measure of BrdU+ 
nuclei/Total nuclei and was repeated in three independent experiments (4 animals for group). 
Values represent mean ± SEM. *, p< 0.01, WT vs K14CRE- Dio3Fl/Fl mice.  
 
Fig.13: K14CRE-Dio3Fl/Fl mice have a proliferative deficit. Cyclin D1 and K14 mRNA expression 
levels were measured in wounded skin at day 6 from damage in WT vs K14CRE-Dio3Fl/Fl mice. The 
values are shown as average ± SD. Western blot analysis shows protein levels of K14 at day 6 of the 
healing process. The protein levels were normalized with ERK-Tot. 
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In order to assess whether the proliferation impairment corresponded to a premature 
differentiation we measured the expression levels of early and terminal differentiation 
markers at different days after wound. Interestingly, mRNA levels of involucrin, loricrin and 
filaggrin are increased in K14CRE- Dio3Fl/Fl after wound (Fig. 14). In addition, RNA and 
protein levels of K10 are also induced in D3-depleted epidermis at day 6 from wound (Fig. 
6b). These data suggest that an hyperthyroid environment in D3-depleted skin drives towards 
an earlier epidermal differentiation. This was also supported by the induction of E-cadherin 
levels (a TH-responsive gene) in K14CRE- Dio3Fl/Fl versus WT wound (Fig.6c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.14: Premature differentiation in K14CRE-Dio3Fl/Fl mice during epidermal regeneration. (a) 
K10, Involucrin, Loricrin and Fillagrin mRNA expression were measured in RNA samples 
extracted from wounded region of skin. Data are expressed as mean ± SD. (b) Immunofluorescent 
staining for K10, E-Cadherin, DAPI or merged images in wounded skin of K14CRE-Dio3Fl/Fl and 
WT mice at day 6 from injury. (c) Western blot analysis of E-Cadherin in proteic extracts of the 
wounds. 
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These wound healing experiments revealed a distinct delay in epidermal regeneration in 
K14CRE- Dio3Fl/Fl mice compared with WT animals. This delay was caused by the defective 
proliferation in the absence of active D3 in the face of an enhanced cellular differentiation of 
keratinocytes. In summary, our data indicate that increased nuclear levels of TH in K14CRE- 
Dio3Fl/Fl keratinocytes compromise the normal epidermal regeneration of the skin.  
 
D3 in the skin plays a central role in thyroxine clearance 
Since D3 is expressed in adult mice only in brain and skin, and given the large mass of skin, 
we speculated that D3 present in the skin may play a role in thyroxine clearance. Indeed, 
when we intraperitoneally injected supraphysiological doses of T4, the ability to metabolize 
T4 by K14CRE-Dio3Fl/Fl mice was reduced of the 40% at 24 hours and of about 33% at 48 
hours from T4 injection (Fig.15). This result led us to uncover a new specific role of 
epidermal D3 in the regulation of plasma TH concentrations by clearance.   
 
                               
 
 
 
 
 
 
Fig.15: K14CRE-Dio3Fl/Fl mice show reduced T4 clearance.(Top) Serum T4 concentrations at 
different times after the intraperitoneal administration of supraphysiological doses of T4 (20 
ug/100g BW). T4 serum levels were represented in relation to the first point of curve (T0, before 
the T4 injection). (Bottom) Scheme of experimental design with the times of collection. 
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DISCUSSION 
 
Although mounting evidence suggests that TH signaling strongly influences epidermal 
homeostasis, the physiologic role of TH in normal and pathological skin is not well 
understood. The importance of TH action in the skin is already evident in lower vertebrates. 
Indeed, in Amphibian metamorphosis, the skin is transformed from a bilayered non-
keratinized epidermis into a stratiﬁed, keratinized epithelium. This transformation is 
controlled by T3 and correlates with the expression of adult keratins and the loss of 
embryonic keratins [83]. In this study, we show that D3, by degrading TH in epidermal cells, 
is necessary for keratinocyte proliferation and proper differentiation. This is reflected in the 
essential requirement for an active D3 in wound repair.  
 
Consequences of D3 depletion in keratinocytes in vitro and in vivo 
 
Here, we showed that an hyperthyroid environment produced by D3 depletion reduces 
keratinocyte proliferation and promotes epidermal differentiation, as demonstrated by 
reduction of Cyclin D1 levels and BrdU incorporation and the increase of specific 
differentiation markers K1, loricrin, Pvrl4 and Dsg1. This is in agreement with previous 
studies [60], which provided the first evidence that THs can inhibit clonal expansion and 
promote differentiation of epithelial progenitors [60]. The reduction of keratinocyte 
proliferation observed in K14CRE-Dio3Fl/Fl mice could be explained by their continuous 
exposition to an excess of TH, and is in agreement with the evidence that T3 and T4 
treatment significantly reduce the colony-forming efficiency, proliferation, cell number 
viability of primary human ORS-keratinocytes and stimulate their apoptosis [60].  
The effect of elevated TH signaling on proliferation and differentiation of keratinocytes is 
reflected on K14CRE-Dio3Fl/Fl skin phenotype, which is characterized by thinner epidermis 
and by a decreased level of K14, a prototypic marker of dividing basal keratinocytes. Tomic-
Canic et al. in 1995 demonstrated that, in the presence of T3, the constitutive activation of  
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T3R on K14 promoter is not only reversed, but the extent of transcriptional activity is further 
inhibited approximately 5-fold below the level of basal expression [36]. This evidence is in 
agreement with the reduction of  the K14 mRNA and protein observed in K14CRE-Dio3Fl/Fl 
epidermis, in which the loss of D3 activity (the major TH inactivator) leads to an 
hyperthyroid environment. 
 
 
 
 
 
 
 
 
 
 
Impact of D3 in the skin on the plasma TH concentrations   
 
T3 is a circulating hormone whose levels are fairly constant and stable in the plasma 
concentration in healthy. Accumulating evidences indicate that the pleiotropic effects on 
growth, metabolism and differentiation are essentially executed through the capacity to 
modulate TH signaling at the single tissue or cell level, without affecting the hormonal 
concentrations in the plasma [14]. Indeed, at plasma level, a potent hypothalamic-pituitary-
thyroid axis preserves systemic T3 circulation by dangerous oscillations with a fine 
homeostatic mechanism controlling hormone secretion by the thyroid gland. In association 
with this particular control, the family of deiodinases constitutes a further potent mechanism 
to control thyroid hormone signaling, allowing cells to customize their own T3 footprint in a 
spatial- and temporal-dependent fashion. Thus, tissues expressing D3 have lower T3 
concentrations than what would be expected from plasma contribution, and virtually D3-
 
Fig.  : Cartoon of K14CRE-Dio3Fl/Fl epidermis. Thinner epidermis and reduction in K14 levels in 
hyperthyroid tissue, when D3is absent.   
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expressing tissues have a gene expression profile typical of hypothyroid cells [14]. Santini et 
al. showed that D3 plays an important role in the clearance of TH by inactivating T4 to rT3. 
They observed that plasma rT3 concentrations increased significantly 6 and 12 h after topical 
application of a T4-containing cream, which demonstrates the presence of D3 activity in 
human skin and indicates that normal human skin serves as a substantial, but incomplete, 
barrier to T(4) passage [84]. In our system, we observed that D3 depletion from the skin does 
not change the plasma TH concentrations in basal conditions. Probably homeostatic 
mechanisms acting at the hypothalamic-pituitary level preserve plasma from changes in TH 
concentrations. However, in response to injection of supraphysiological doses of T4, the 
ability to metabolize T4 from the plasma is strongly reduced with no D3 in the skin. Our 
results show for the first time that D3 in the skin is necessary for proper T4 clearance, 
revealing a new specific role for D3 in epidermal context.  
 
D3-mediated control of TH signaling is necessary for proper wound healing  
 
T3 is a well-known differentiating agent. Recent studies have shown a close relationship 
between TH metabolism, via deiodinases expression, and the regulatory networks that 
control tissue repair. This leads to the concept that finely tuned TH concentration is essential 
in the control of the proliferation and differentiation balance necessary in the regeneration 
processes. In this scenario, massive induction of D3 expression in the early phases of 
regeneration may well correlate with a requirement of increased cellular proliferation. 
Presumably the induction of D3 leads to a localized region of hypothyroidism within the 
tissue, and this could influence healing or regenerative processes. In this regard, considerable 
interest has been generated by recent observations that D3 is induced in vivo at sites of tissue 
injury and inflammation and in cell culture systems by conditions of hypoxic or oxidative 
stress [15-16]. Moreover, D3 induction has been observed in animal models at sites of local 
inflammation [85] in peripheral nerves in response to cryolesion-induced injury [73], and in 
the heart in the setting of myocardial infarction [74] and cardiac hypertrophy [86]. D3 
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expression was strongly induced in the liver of mice and rats in a model of liver regeneration 
induced by partial hepatectomy [72]. With the present study, we propose for the first time 
that D3 is induced during epidermal wound healing. There are many evidence that confirm 
the importance of T3 during wound healing, and indeed it is known that hypothyroid states 
result in poorer wound healing [87]. Despite this the reported data about requirement for 
local control of TH signaling during epidermal proliferation and wound healing is still very 
contradictory [87-88-89-90-91].  Lennox and Johnston reported that exogenous T4 improved 
the rate of wound healing in rats as well as the strength of the scars. They further reported 
that wound-healing speed was diminished in hypothyroid rats [92]. Mehregan and Zamick 
observed that additional TH stimulated the rate and quality of wound healing in euthyroid 
rats. Scars were smoother in animals receiving T3 in drinking water [88-89]. Pirk et al. noted 
no change in wound healing with euthyroid hamsters receiving ip T4 [90]. Cannon reported 
that hypothyroidism did not diminish wound strength in pigs [93], and Ladenson et al. found 
no wound healing deficits in hypothyroid humans [94]. The hormone replacement therapy in 
hypothyroidism cases was beneficial with regard to wound healing [65]. Finally, the same 
study of Safer JD in 2005 highlights a conflicting data regard to T3 treatment of wounds. 
Mice treated with 3.8 ug of topical T3 daily did not have wound healing acceleration beyond 
that of the mice treated with 150 ng T3 daily. Mice treated with ip T3 did not have wound 
healing acceleration beyond that of control mice [58]. In this work the authors speculate that 
a lower dose of T3 could be administered and accelerate wound healing with even less 
systemic consequence than seen with the 150-ng T3 dose. Moreover, they affirm that the 
topical treatment would be useful for situations requiring rapid healing with little concern for 
the scar quality, as the authors do not evaluate the wound quality. In another their work of 
2003, Safer et al. affirm that TH mediates inhibition of keratinocyte growth when themselves 
are co-coltured with dermal fibroblasts [57]. Thus, in vivo, skin proliferation directly 
stimulated by T3 may be offset by inhibiting factors dependent on the systemic T3 [95]. In 
the present study, we determined that D3 strongly increases in the early phases of 
regeneration after injury and decreases in the late phases of tissue repair (Fig.5). Importantly, 
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our data show that the epidermis of K14CRE-Dio3Fl/Fl mice exhibits a regenerative defect 
after injury with a delayed closure of wound area (Fig.11). Indeed, D3-depleted epidermis 
displays a fewer number of proliferating cells around damage site with a reduced BrdU 
incorporation (Fig.12). We do not still know if this proliferating defect is due to a reduced 
migration of wound invading cells or to an increased cellular apoptosis triggered by 
hyperthyroid environment. Our preliminary data indicated that D3-depleted keratinocytes 
have an inability to migrate respect to WT cells. On the other hand, a link between excessive 
thyroid hormone and apoptosis has been previously demonstrated in amphibian 
metamorphosis [96]. All metamorphic changes that take place during body remodeling are 
controlled by T3, which causes developmental programmed cell death through apoptosis in 
tadpole tails to reshape them to acquire the adult form [97-98-99]. Moreover in human and 
mouse basal cell carcinoma cells where excessive T3, consequent to D3 depletion, induces 
apoptosis of tumoral cells [17]. Further studies are necessary to better understand the 
underlying mechanism of delayed wound healing in D3-depleted skin.  
Our data demonstrate for the first time that the presence of D3 in the skin is necessary for 
proper epidermal homeostasis and for regular wound healing and that then the tissue 
thyrotoxicosis compromises a normal epidermal regeneration, owing to slowed proliferation 
and accelerated differentiation, specifically.  
 
Finally, these discoveries extend insight into TH action on skin, providing new knowledge 
about the role of deiodinases, and in particular of D3 on skin biology and during skin 
regeneration. Unfortunately, our knowledge about molecular causes and effects of TH action 
remains largely incomplete, especially regarding molecular pathway governing D3 in the 
normal skin and during regeneration processes. Putative upstream regulators of D3 in 
keratinocytes are not known at the present. Multiple growth factors and hormones regulate 
D3 activity by inducing D3 mRNA expression [34-100]. Among them, the TGFβ signaling is 
one of these [101]. Many recent evidence associate TGFβ signaling with wound healing and 
epidermal regeneration processes [102-103-104], besides the fact that the TGFβ promotes 
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the basal phenotype of epidermal keratinocytes by transcriptional induction of K14 and K5 
keratin genes [105], both target of TH. Thus, further studies on the interplay between TGF-β 
and TH signaling pathways could help to test new specific pharmacological and molecular 
genetic approaches targeting the D3 gene in this scenario. 
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CONCLUSIONS 
 
The skin exhibits typical abnormalities in hyperthyroidism and hypothyroidism and it is well 
known that thyroid dysfunction is associated with skin pathologies. Smooth, thin and warm 
skin are epidermal changes in thyrotoxicosis states, in association with hair and nail changes 
as fine hair (loses wave), alopecia, shiny, soft and friable nails.  
Recent studies have shown a close relationship between TH metabolism, via deiodinases 
expression, and the regulatory networks that control the single specific requirements of the 
cell. This leads to the concept that finely tuned TH concentration is essential in the control of 
the proliferation and differentiation balance necessary in many tissue processes in which the 
deiodinases are expressed. 
This study provides a new specific role for type 3 deiodinase, the principal terminator of TH 
action, in the skin. The data in this thesis define that D3 is essential in epidermal 
regeneration processes. In this scenario, massive induction of D3 expression in the early 
phases of regeneration may well correlate with a requirement of increased cellular 
proliferation in these circumstances. Our data demonstrate for the first time that the presence 
of D3 in the skin is necessary for proper epidermal homeostasis and for regular wound 
healing. Tissue thyrotoxicosis compromises a normal epidermal regeneration, especially 
acting through a proliferation slowness and differentiative acceleration. 
The possibility to target therapeutically one specific deiodinase, in a defined cellular context, 
opens new potential approaches to the treatment of selective and somehow ‘T3-sensitive’ 
cutaneous diseases. Further studies are necessary to a better understanding the molecular 
pathways at the basis of TH action in the skin and to allow a clinical approach in hypo- and 
hyperthyroidism to treat specific skin symptoms. 
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MATERIALS AND METHODS 
 
Generation of  K14CRE-Dio3Fl/Fl mice. We generated a plasmid harboring floxed sites in the 
dio3 locus, and specifically flanking the SECIS mRNA structure located at nt 933 and 1609 
in the dio3 mRNA. This region is necessary for the proper recognition of the TGA coding as 
a selenocysteine recognition codon rather than a conventional STOP codon. In absence of 
the SECIS, the TGA codon, within the D3 catalytic domain, is recognized as stop codon, and 
protein translation terminated. Once obtained the homozygous Dio3Flox/Flox mice, we crossed 
these mice with heterozygous ACTB-FLP1 mice, expressing the FLPe recombinase variant 
transgene Flp that catalyze the recombination between the frt sites, flanking the neomycin 
cassette. Progressively, we crossed the Dio3flox/flox mice without FLP with K14CRE mouse, 
and we inbreeded the animals up to obtain the K14CRE-Dio3Fl/Fl mouse line. Since D3 is 
parentally imprinted, we used only male mice K14CRE-Dio3Fl/Fl for crossing and we used as 
control the Dio3Fl/Fl mouse.  
 
T4 Clearance experiment. 8 week old mice were intraperitoneally (i.p.) injected with 
20ug/100g of T4. Starting one day before injection, the blood was collected by retro-orbital 
withdrawal at 24 and 48 hours after a single T4 injection. The serums were separated and the 
determination of T4 was measured by Rodent T4 Elisa Test Kit (Endocrine Technologies 
Inc. USA). Experiments were performed with 6 mice per group and repeated two times in 
these conditions. The difference were statistically significant. All mouse experiments were 
approved by the Italian Ministry of Health. 
Excisional wound preparation and analysis. 2 Full-thickness wounds were created in the 
dorsal skin under sterile conditions. Briefly, mice were anesthetized with i.p. administration 
of avertin. After shaving and cleaning with betadine and 70% ethanol, the dorsal skin was 
picked up at the midline and punched through two layers of skin with a sterile disposable 
scalpel generating one wound of 8mm x 8mm on each side of the midline. Each wound site 
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was digitally photographed at the indicated time intervals, and wound areas were determined 
on photographs using Adobe PhotoShop (version 7.0; Adobe Systems). Changes in wound 
areas over time were expressed as the percentage of the initial wound areas. The mice were 
killed at different time points after injury and wounds were either embedded for sectioning 
or excised including 2 mm of the epidermal margins for RNA and protein isolation. Three 
animals were analyzed per genotype and time point. All mouse experiments were approved 
by the Italian Ministry of Health. 
Histology, Immunostaining and Immunoblotting. Mouse tissue was fixed in 4% PFA and 
embedded in paraffin wax.  For epidermal thickness analysis, 6 um serial paraffin sections of 
uninjured and wounded skin were cut and stained with hematoxylin & eosin (H&E) and the 
measurements were executed by CellF Software. For assessment of BrdU incorporation, 
mice were injected ip with 1 ml/100 g body weight of BrdU (Zymed, Invitrogen) 3 hours 
before harvesting the skins, according to the manufacturer’s protocol. Immunofluorescence 
was performed using anti-BrdU, -K14, -K10, or -E Cadh  Abs. Deparaffinized sections were 
permeabilized with 0,5% Triton, unmasked in Citrate Sodium 0,01M ph 6.0 and blocked 
with Avidin/Biotin Blocking kit to eliminate endogenous biotin. The sections were further 
incubated with PBS containing 5% goat serum and 6% BSA to reduce nonspecific reactions. 
The sections were incubated with primary Abs at 4°C overnight. Normal histoblock reagent 
was used as negative control. After incubation with biotinylated mouse, rabbit or goat 
secondary Abs, immune complexes were cross interacted with Streptavidin-Cy3 reagent 
(Sigma) and visualized using the OLYMPUS IX51 microscope, according to the 
manufacturer’s instructions. 
Cell cultures and reagents. Wild-type, D3Fl/Fl and K14CRE-Dio3Fl/Fl mutant primary mouse 
keratinocytes were isolated from newborn mice. Their skins were placed in dispase o/n at 
4°C by dispase treatment (Dispase I, Roche) and then keratinocytes were isolated from 
epidermis by enzymatic dissociation in trypsin, and cultured under low Ca2+ conditions (0.02 
mM). The infection experiments were performed with 75 MOI of AdCRE-GFP and AdGFP 
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virus. To evaluate proliferation, cells were incubated with BrdU labelling reagent (B-5002 
Sigma) for 2h before of the harvest. For immunofluorescence staining, cells were fixed with 
4% formaldehyde and permeabilized with 50mM NaOH, then blocked with 5% goat serum 
and incubated with monoclonal Ab G3G4 (Developmental Studies Hybridoma Bank) and 
DNase. Alexa Fluor 595–conjugated secondary antibody was used. The cell DNA was 
stained with 300 nM DAPI (Molecular Probes, Invitrogen).   
 
Real-Time RT-PCR. Skin and keratinocytes RNA were extracted in TRIzol reagent 
(Invitrogen). Nuclear RNA was treated with DNase I (Roche). Complementary DNA 
(cDNA) synthesis was obtained using SuperScript III (Invitrogen). Real-time PCR was 
performed using the SYBR Green PCR master mix (Biorad) in an iQ5 Cycler (Biorad). 
Expression of target genes was normalized for cyclophilin A. For primer sequences see 
Table below. 
 
Gene Primer sequences (5’- 3’) 
Cyclofillin A   F - CGCCACTGTCGCTTTTCG 
 R - AACTTTGTCTGCAAACAGCTC 
Cyclin D1   F - GCTCCTGTGCTGCGAAGTGGA 
 R - TCATGGCCAGCGGGAAGACCT 
Desmosglein1  F -
CCACCTGATAACGCAAATATAATTG 
R - TTGCATTTCTCTGCCACCATAC 
Fillagrin F - GTCCAAAGTGCAGCAGCAAG 
R -
TTAAAATCAAGGTGCTTTGCTGTAA 
Involucrin F - AAAGCTTCAAGGGAACAGCA 
R - CGGTTCTTCAATTCGTGTTT 
Keratin 1  F - TCGTGACCATCAAGAAGGAT 
R - ACAACATTGGTTTCGCTGAT  
Keratin 10 F- CGTTGGCATTGTCAGTTGTC 
R - CGAGCTGGAGGGTAAAATCA 
Keratin 14 F - GATGTGACCTCCACCAACCG 
R - CCATCGTGCACATCCATGAC 
Loricrin F - CCTTCACATTTTAAGCGCCC 
R - TGAGCGACTCAATGGCTTCTT 
Poliovirus 
receptor-related 4  
F - GGCATCGTTTACAGGCCAAT 
R – AGCACCACTGTCACTACGTCAGA 
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Statistics. Differences between samples were assessed by Student’s 2-tailed t test for 
independent samples. P values less than 0.05 were considered significant. Relative mRNA 
levels (in which the first sample was arbitrarily set as 1) are reported as results of real-time 
PCR in which expression of cyclophilin A was used as a housekeeping gene. 
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